US HB2883 | 2021-2022 | 117th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 6-3)
Status: Introduced on April 28 2021 - 25% progression, died in chamber
Action: 2021-09-29 - Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 28 2021 - 25% progression, died in chamber
Action: 2021-09-29 - Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
Text: Latest bill text (Introduced) [PDF]
Summary
To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.
Title
Stop Stalling Access to Affordable Medications
Sponsors
Rep. Hakeem Jeffries [D-NY] | Rep. Ken Buck [R-CO] | Rep. Jerrold Nadler [D-NY] | Rep. David Cicilline [D-RI] |
Rep. Carolyn Maloney [D-NY] | Rep. Burgess Owens [R-UT] | Rep. Sheila Jackson-Lee [D-TX] | Rep. Val Demings [D-FL] |
Sen. Ted Budd [R-NC] |
History
Date | Chamber | Action |
---|---|---|
2021-09-29 | House | Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9. |
2021-09-29 | House | Committee Consideration and Mark-up Session Held. |
2021-04-28 | House | Referred to the House Committee on the Judiciary. |
2021-04-28 | House | Introduced in House |
Same As/Similar To
SB1425 (Related) 2021-12-08 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 179.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/house-bill/2883/all-info |
Text | https://www.congress.gov/117/bills/hr2883/BILLS-117hr2883ih.pdf |